🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-523601-16-00
Authorised Phase I

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

2025-523601-16-00 · tracked via the Priya Life Science EU tracker
Sponsor
Eli Lilly & Co.
Sponsor type
Pharmaceutical company
Therapeutic area
Neoplasms
Decision date
08/09/2026
Enrollment target
188
Sites
Spain, Poland, Italy, France, Germany

Condition studied

Lymphoma, Non-Hodgkin's Lymphoma, Diffuse Large B-Cell Follicular Lymphoma

Eligibility

Age group
18-64 years, 65+ years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-523601-16-00 on CTIS ↗ ← All trials in the EU